Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | Patent Number 11780911
US 11780911 B2Filled DateMay 21, 2020
Priority DateMay 23, 2019
Publication DateNov 26, 2020
Expiration DateMay 22, 2039
Inventor/ApplicantsMatthew Germinaro
Jacqueline Perrigoue
Mathew Germinaro
Christopher O'Brien
Jacqueline Perrigoue
Mathew Germinaro
Christopher O'Brien
ExaminesHAMUD, FOZIA M
Art Unit1647
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.